Image of Joe
Just B

Because life is bigger than hemophilia B

Since switching to IXINITY®, I have not yet had a breakthrough bleed. I feel confident that I’m covered and can go about my everyday life.

Joe uses IXINITY*
*This information is based on this individual’s experience. Different patients may have different results.
Image of Nathan
Just B

Because life is bigger than hemophilia B

Since switching, I’m more willing to just jump in and go because I’m confident that I’m covered with IXINITY®.

Nathan uses IXINITY*
*This information is based on this individual’s experience. Different patients may have different results.
Image of Erica
Just B

Because life is bigger than hemophilia B

I love being active, and I’m determined not to let hemophilia change that. With IXINITY®, I feel confident that I’m covered.

Erica uses IXINITY*
*This information is based on this individual’s experience. Different patients may have different results.
Image of Manny
Just B

Because life is bigger than hemophilia B

The people at Aptevo were a key reason why I chose to switch to IXINITY®. There’s a personalized approach and a willingness to connect in a very human way.

Manny uses IXINITY*
*This information is based on this individual’s experience. Different patients may have different results.
Image of Collin
Just B

Because life is bigger than hemophilia B

Aptevo is just a close group of genuinely nice people; it feels like a family. I wanted to be a part of that, which is one of the main reasons I switched to IXINITY®.

Collin uses IXINITY*
*This information is based on this individual’s experience. Different patients may have different results.
Image of Hakeem
Just B

Because life is bigger than hemophilia B

I feel good knowing that I have IXINITY® by my side when I need it. I like that I can infuse and get on with my day. I don’t feel like I’m missing out on things.

Hakeem uses IXINITY*
*This information is based on this individual’s experience. Different patients may have different results.

Connect with your local Hemophilia Territory Manager and see if IXINITY is the right treatment for your patients.

Find my rep
Up to 20,000 IU.

INDICATIONS AND IMPORTANT SAFETY INFORMATION

Expand

INDICATIONS AND USAGE: IXINITY® [Coagulation Factor IX (Recombinant)] Lyophilized Powder for Solution for Intravenous Injection is a coagulation factor IX (recombinant) indicated in adults and children ≥12 years of age with hemophilia B for control and prevention of bleeding episodes, and for perioperative management.

IXINITY is not indicated for induction of immune tolerance in patients with hemophilia B.

CONTRAINDICATIONS: IXINITY is contraindicated in patients who have known hypersensitivity to IXINITY or its excipients, including hamster protein.

WARNINGS AND PRECAUTIONS: Hypersensitivity reactions, including anaphylaxis, may occur following IXINITY administration. Discontinue use of IXINITY if hypersensitivity symptoms occur, and initiate appropriate treatment. Regularly evaluate patients for the development of factor IX inhibitors by appropriate clinical observations and laboratory tests. If expected factor IX activity plasma levels are not attained, or, if bleeding is not controlled as expected with a certain dose, perform an assay that measures factor IX inhibitor concentration. An association between the occurrence of a factor IX inhibitor and allergic reactions has been reported. Individuals with factor IX inhibitors may be at increased risk of severe hypersensitivity reactions or anaphylaxis if re-challenged.

Nephrotic syndrome may occur with IXINITY. Nephrotic syndrome has been reported following attempted immune tolerance induction in hemophilia B patients with factor IX inhibitors and a history of allergic reactions.

Thromboembolism may occur when using IXINITY (e.g., pulmonary embolism, venous thrombosis, and arterial thrombosis).

Patients may develop hypersensitivity to hamster (CHO) protein as IXINITY contains trace amounts.

The most common adverse drug reaction observed in >2% of patients in clinical trials was headache.

Please see full Prescribing Information.

Medical Affairs e-mail: MedicalAffairs@apvo.com

To report an adverse event, please call 1-844-859-6675.